Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Join us for a symposium on metabolic dysfunction-associated steatohepatitis (MASH) designed to encourage the exchange of ideas between leaders in the field and attendees.

Supported by: Inventivia

Organized by: Medscape Education

For more information and to register, visit: https://events.medscapelive.org/website/88600/

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Come discuss the science behind the recent Hepatology review article on HBV Biomarkers with Hepatology Associate Editor Dr.  Fabien Zoulim. Read the article here: https://journals.lww.com/hep/fulltext/9900/getting_to_hbv_cure_will_new_biomarkers_help_.1222.aspx
 
3:45-3:55 PM- Presentation
3:55-4:15 PM- Audience Q&A and Discussion
 

National Cancer Institute program staff will discuss current funding opportunities for basic and clinical research at the National Cancer Institute and take questions regarding the grant process and funding opportunities.

The Summary of TERLIVAZ® (terlipressin): the first FDA-approved treatment for HRS in adults with rapid reduction in kidney function. TLM theater will highlight the importance of early recognition and current diagnosis and treatment recommendations for hepatorenal syndrome–acute kidney injury (HRS-AKI).

Industry Supporter: Mallinckrodt Pharmaceuticals